We have located links that may give you full text access.
Multinational descriptive analysis of the real-world burden of headache using the Migraine Buddy application.
European Journal of Neurology 2021 July 27
BACKGROUND: A large proportion of headache sufferers do not routinely seek medical care. App-based technologies permit the collection of real-world data over time and between countries that can help assess true burden of headache. This study used a mobile phone application to collect information on real-world burden of self-diagnosed headache and to describe its impact on daily life in headache sufferers who do not routinely seek medical advice.
METHODS: This retrospective, non-interventional, cross-sectional study analysed self-reported data from users of the 'Migraine Buddy' app. The main objective was to describe self-reported characteristics of headache and migraine (triggers, duration, frequency), treatment patterns and impact on daily activity in headache sufferers from Australia, Brazil, France, Germany, Japan. Data including demographics, self-diagnosed episode type (headache/migraine), duration, potential triggers, and impact on daily activity are reported. All analyses were exploratory and performed per country.
RESULTS: Self-reported data were collected from 60,474 users between August 2016-August 2018. Approximately 90% of users were females; >60% was aged 24-45 years. Over one-third of users reported having 2-5 episodes of headache or migraine per month; impact included impaired concentration, being slower and missing work or social activities. Variation across countries were observed; within countries, episode characteristics were very similar for self-diagnosed headache vs migraine.
CONCLUSIONS: We used headache tracking to describe the experience, impact and self-management approaches of migraine and headache sufferers in real-world setting. Headache disorders present a range of important issues for patients that deserve more study and reinforce the need for better approaches to management.
METHODS: This retrospective, non-interventional, cross-sectional study analysed self-reported data from users of the 'Migraine Buddy' app. The main objective was to describe self-reported characteristics of headache and migraine (triggers, duration, frequency), treatment patterns and impact on daily activity in headache sufferers from Australia, Brazil, France, Germany, Japan. Data including demographics, self-diagnosed episode type (headache/migraine), duration, potential triggers, and impact on daily activity are reported. All analyses were exploratory and performed per country.
RESULTS: Self-reported data were collected from 60,474 users between August 2016-August 2018. Approximately 90% of users were females; >60% was aged 24-45 years. Over one-third of users reported having 2-5 episodes of headache or migraine per month; impact included impaired concentration, being slower and missing work or social activities. Variation across countries were observed; within countries, episode characteristics were very similar for self-diagnosed headache vs migraine.
CONCLUSIONS: We used headache tracking to describe the experience, impact and self-management approaches of migraine and headache sufferers in real-world setting. Headache disorders present a range of important issues for patients that deserve more study and reinforce the need for better approaches to management.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app